-transparent.png){kind=logo}
Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma. 2020
Clémentine Boccon-Gibod, and
Alexis Talbot, and
Fabien Le Bras, and
Laurent Frenzel, and
Bruno Royer, and
Stephanie Harel, and
Naelle Lombion, and
Karim Belhadj, and
Wendy Cuccuini, and
Bertrand Arnulf
Immuno-hematology Department, Hôpital Saint-Louis, APHP, Paris, France.
Related Publications
Clémentine Boccon-Gibod, and
Alexis Talbot, and
Fabien Le Bras, and
Laurent Frenzel, and
Bruno Royer, and
Stephanie Harel, and
Naelle Lombion, and
Karim Belhadj, and
Wendy Cuccuini, and
Bertrand Arnulf
October 2021,
Blood advances,
Clémentine Boccon-Gibod, and
Alexis Talbot, and
Fabien Le Bras, and
Laurent Frenzel, and
Bruno Royer, and
Stephanie Harel, and
Naelle Lombion, and
Karim Belhadj, and
Wendy Cuccuini, and
Bertrand Arnulf
January 2019,
Cancer management and research,
Clémentine Boccon-Gibod, and
Alexis Talbot, and
Fabien Le Bras, and
Laurent Frenzel, and
Bruno Royer, and
Stephanie Harel, and
Naelle Lombion, and
Karim Belhadj, and
Wendy Cuccuini, and
Bertrand Arnulf
November 2015,
Blood,
Clémentine Boccon-Gibod, and
Alexis Talbot, and
Fabien Le Bras, and
Laurent Frenzel, and
Bruno Royer, and
Stephanie Harel, and
Naelle Lombion, and
Karim Belhadj, and
Wendy Cuccuini, and
Bertrand Arnulf
January 2015,
The New England journal of medicine,
Clémentine Boccon-Gibod, and
Alexis Talbot, and
Fabien Le Bras, and
Laurent Frenzel, and
Bruno Royer, and
Stephanie Harel, and
Naelle Lombion, and
Karim Belhadj, and
Wendy Cuccuini, and
Bertrand Arnulf
January 2018,
The Lancet. Oncology,
Clémentine Boccon-Gibod, and
Alexis Talbot, and
Fabien Le Bras, and
Laurent Frenzel, and
Bruno Royer, and
Stephanie Harel, and
Naelle Lombion, and
Karim Belhadj, and
Wendy Cuccuini, and
Bertrand Arnulf
October 2012,
Drugs,
Clémentine Boccon-Gibod, and
Alexis Talbot, and
Fabien Le Bras, and
Laurent Frenzel, and
Bruno Royer, and
Stephanie Harel, and
Naelle Lombion, and
Karim Belhadj, and
Wendy Cuccuini, and
Bertrand Arnulf
August 2019,
Blood,
Clémentine Boccon-Gibod, and
Alexis Talbot, and
Fabien Le Bras, and
Laurent Frenzel, and
Bruno Royer, and
Stephanie Harel, and
Naelle Lombion, and
Karim Belhadj, and
Wendy Cuccuini, and
Bertrand Arnulf
January 2018,
The Lancet. Oncology,
Clémentine Boccon-Gibod, and
Alexis Talbot, and
Fabien Le Bras, and
Laurent Frenzel, and
Bruno Royer, and
Stephanie Harel, and
Naelle Lombion, and
Karim Belhadj, and
Wendy Cuccuini, and
Bertrand Arnulf
January 2019,
American journal of hematology,
Clémentine Boccon-Gibod, and
Alexis Talbot, and
Fabien Le Bras, and
Laurent Frenzel, and
Bruno Royer, and
Stephanie Harel, and
Naelle Lombion, and
Karim Belhadj, and
Wendy Cuccuini, and
Bertrand Arnulf
January 2020,
Future oncology (London, England),
